41![LGS A MONTHLY NEWSLETTER FOR HEALTH CARE PROVIDERS TREATING PATIENTS WITH LENNOX-GASTAUT SYNDROME www.lgshope.com LGS A MONTHLY NEWSLETTER FOR HEALTH CARE PROVIDERS TREATING PATIENTS WITH LENNOX-GASTAUT SYNDROME www.lgshope.com](https://www.pdfsearch.io/img/a186b0909f58d1a8819f95094e3ab9e0.jpg) | Add to Reading ListSource URL: www.lgshope.comLanguage: English - Date: 2013-11-05 11:19:03
|
---|
42![LGS A MONTHLY NEWSLETTER FOR HEALTH CARE PROVIDERS TREATING PATIENTS WITH LENNOX-GASTAUT SYNDROME www.lgshope.com LGS A MONTHLY NEWSLETTER FOR HEALTH CARE PROVIDERS TREATING PATIENTS WITH LENNOX-GASTAUT SYNDROME www.lgshope.com](https://www.pdfsearch.io/img/2d7c1943ffe8d3018c168d76c6f4988d.jpg) | Add to Reading ListSource URL: www.lgshope.comLanguage: English - Date: 2013-10-01 16:34:01
|
---|
43![CBD as a potential treatment for intractable epilepsy by Orrin Devinsky, MD Marijuana (Cannabis sativa and indica) is a naturally growing plant with many chemical constituents present in varying levels in the different CBD as a potential treatment for intractable epilepsy by Orrin Devinsky, MD Marijuana (Cannabis sativa and indica) is a naturally growing plant with many chemical constituents present in varying levels in the different](https://www.pdfsearch.io/img/f24a9d78ab59d08ee98aeefb4567c489.jpg) | Add to Reading ListSource URL: www.state.ia.usLanguage: English - Date: 2014-09-09 08:21:46
|
---|
44![CBD as a potential treatment for intractable epilepsy by Orrin Devinsky, MD Marijuana (Cannabis sativa and indica) is a naturally growing plant with many chemical constituents present in varying levels in the different CBD as a potential treatment for intractable epilepsy by Orrin Devinsky, MD Marijuana (Cannabis sativa and indica) is a naturally growing plant with many chemical constituents present in varying levels in the different](https://www.pdfsearch.io/img/e4c1ee7134898bb63ef94cf4cb354d8a.jpg) | Add to Reading ListSource URL: www.state.ia.usLanguage: English - Date: 2014-09-09 08:21:46
|
---|
45![Microsoft Word - copy for T sbd_smd_2011_banzel_139913-eng.doc Microsoft Word - copy for T sbd_smd_2011_banzel_139913-eng.doc](https://www.pdfsearch.io/img/a490e7badd3c8ddd5e346a49a7ab488c.jpg) | Add to Reading ListSource URL: hc-sc.gc.caLanguage: English - Date: 2013-06-24 11:52:28
|
---|
46![Topamax Pediatric Safety and Use Review Topamax Pediatric Safety and Use Review](https://www.pdfsearch.io/img/47930dbde9bbb44370b12c55840f9141.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
47![Curriculum Vitae: Lynn Kramer Curriculum Vitae: Lynn Kramer](https://www.pdfsearch.io/img/556d624050910b5d631aefb268d4f954.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
48![Microsoft PowerPoint - TOPAMAX finals HANDOUT- Elgin.ppt Microsoft PowerPoint - TOPAMAX finals HANDOUT- Elgin.ppt](https://www.pdfsearch.io/img/d56367776b00496dcb11d75374166ca4.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
49![Pediatric Focused Safety Review: Lamictal XR (lamotrigine extended-release) Pediatric Focused Safety Review: Lamictal XR (lamotrigine extended-release)](https://www.pdfsearch.io/img/7cf3bc6c17470999799c09aff0948fb9.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
50![NDA[removed]S-027 FDA Approved Labeling Text dated[removed]Page 1 1 2 NDA[removed]S-027 FDA Approved Labeling Text dated[removed]Page 1 1 2](https://www.pdfsearch.io/img/0edd47d918c407738aeaec1aeeca09b7.jpg) | Add to Reading ListSource URL: www.accessdata.fda.govLanguage: English - Date: 2012-09-06 14:05:10
|
---|